Page last updated: 2024-10-29

ketanserin and Algodystrophic Syndrome

ketanserin has been researched along with Algodystrophic Syndrome in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Ketanserin, a selective S2 serotonergic antagonist, was assessed against placebo in a double-blind cross-over study of 16 patients with chronic peripheral burning pain."9.06Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial. ( Hanna, MH; Peat, SJ, 1989)
"Ketanserin, a selective S2 serotonergic antagonist, was assessed against placebo in a double-blind cross-over study of 16 patients with chronic peripheral burning pain."5.06Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial. ( Hanna, MH; Peat, SJ, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bounameaux, HM1
Hellemans, H1
Verhaeghe, R1
Hanna, MH1
Peat, SJ1

Trials

2 trials available for ketanserin and Algodystrophic Syndrome

ArticleYear
Ketanserin in chronic sympathetic dystrophy. An acute controlled trial.
    Clinical rheumatology, 1984, Volume: 3, Issue:4

    Topics: Adult; Clinical Trials as Topic; Female; Humans; Ketanserin; Male; Middle Aged; Piperidines; Reflex

1984
Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial.
    Pain, 1989, Volume: 38, Issue:2

    Topics: Adult; Aged; Double-Blind Method; Female; Humans; Ketanserin; Male; Middle Aged; Pain; Placebos; Ref

1989